Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 139 for “"Cancer Cachexia"”.

  1. Role of Sex Differences on Cancer Cachexia Progression and Fibrosis during Cancer Cachexia Development

    Cancer cachexia is a multifactorial wasting syndrome characterized by losses in bodymass >5% and occurs in approximately 80% of all cancer patients. Chronic inflammation and fibrosis play roles in cancer cachexia and a greater understanding of these contributing pathways to this pathology will pave …

    arkansas Repository record for Role of Sex Differences on Cancer Cachexia Progression and Fibrosis during Cancer Cachexia Development (opens in a new tab)

  2. Phenotypes and genetic markers of cancer cachexia

    Cancer cachexia is a chronic wasting syndrome characterised by loss of weight, composed principally of muscle and fat. Patients with advanced cachexia demonstrate loss of appetite, early satiety, severe weight loss, weakness, anaemia and fluid retention. Affected individuals are also likely to …

    edinburgh Repository record for Phenotypes and genetic markers of cancer cachexia (opens in a new tab)

  3. Mechanism of muscle protein degradation in Cancer Cachexia

    … weight 24 KDa (p24) was purified both from the cachexia-inducing MAC 16 tumour and the urine of cachectic cancer patients by a combination of ammonium sulphate precipitation and affinity chromatography using a monoclonal antibody developed against the murine material. Administration of p24 to …

    aston Download PDF for Mechanism of muscle protein degradation in Cancer Cachexia (opens in a new tab)

  4. Purification and characterisation of two cancer cachexia factors

    Cachexia is a wasting phenomenon that often accompanies malignant disease. Its manifestation is associated with shortened survival and reduced responsiveness to anti-tumour therapy and as yet there is no established, effective amelioratory treatment. The MAC 16 model of cancer cachexia has been …

    aston Download PDF for Purification and characterisation of two cancer cachexia factors (opens in a new tab)

  5. RNA Sequencing in the Development of Cancer-Cachexia

    Introduction: Cancer is a major public health problem in the U.S. and the world. In 2013 there were an estimated 1,660,290 new cases of cancer in the U.S. Cancer-Cachexia (CC) is a common effect of many cancers, and is directly responsible for 20-40% of cancer-related deaths. The mechanisms that …

    arkansas Repository record for RNA Sequencing in the Development of Cancer-Cachexia (opens in a new tab)

  6. Musculoskeletal Effects of Oncostatin M in Pancreatic Cancer Cachexia

    … (PDAC) is the third leading cause of cancerrelated deaths with a five-year survival rate of 11%. PDAC tumors are characterized by a dense desmoplastic stromal microenvironment, mediated in part through local cytokine production. PDAC tumors also elicit a systemic inflammatory response …

    iupui Repository record for Musculoskeletal Effects of Oncostatin M in Pancreatic Cancer Cachexia (opens in a new tab)

  7. Cancer Heterogeneity and Mitochondrial-Targeted Therapies in Cancer Cachexia

    Cancer Cachexia (CC) is a multifactorial and complex syndrome affecting up to 80% of cancer patients and contributing to approximately 40% of cancer-related deaths. Given its relationship with patients' quality of life and prognosis, there has been increasing emphasis on understanding the …

    arkansas Repository record for Cancer Heterogeneity and Mitochondrial-Targeted Therapies in Cancer Cachexia (opens in a new tab)

  8. Targeting cancer cachexia via inhibition of soluble epoxide hydrolase

    Cancer cachexia is an incapacitating condition characterized by progressive muscle wasting and hyperinflammation, for which there are currently no effective therapeutic remedies available. The underlying mechanisms of cachexia remain poorly understood. However, studies now understand the …

    bu Repository record for Targeting cancer cachexia via inhibition of soluble epoxide hydrolase (opens in a new tab)

  9. The role of pro-resolving mediators in cancer cachexia

    Cancer cachexia is a complex and multifactorial syndrome characterized by persistent inflammation, leading to severe muscle wasting, weight loss, and metabolic dysfunction. Conventional anti-inflammatory approaches have exhibited limited efficacy in effectively managing patient outcomes, …

    bu Repository record for The role of pro-resolving mediators in cancer cachexia (opens in a new tab)

  10. Mechanism of protein catobolism in skeletal muscle during cancer cachexia

    Cancer cachexia is characterised by selective depletion of skeletal muscle protein reserves. The ubiquitin-proteasome proteolytic pathway has been shown to be responsible for muscle wasting in a range of cachectic conditions including cancer cachexia. To establish the importance of this pathway in …

    aston Download PDF for Mechanism of protein catobolism in skeletal muscle during cancer cachexia (opens in a new tab)

  11. Cellular signalling pathways involved in muscle atrophy in cancer cachexia

    Cancer cachexia encompases severe weight loss, characterised by the debilitating atrophy of adipose and skeletal muscle mass. Skeletal muscle proteolysis in cancer cachexia is mediated by a sulphated glycoprotein with a relative molecular mass of 24kDa, termed Proteolysis-Inducing Factor (PIF). PIF …

    aston Download PDF for Cellular signalling pathways involved in muscle atrophy in cancer cachexia (opens in a new tab)

  12. Exploring the Immune System’s and Silybin’s Impact on Cancer Cachexia

    Cancer cachexia is a complex syndrome that is characterized by the unintentional loss of body weight with or without fat loss. During cancer cachexia, there is an increase in inflammation consistent with various inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), Interleukin-1 beta …

    south-carolina Repository record for Exploring the Immune System’s and Silybin’s Impact on Cancer Cachexia (opens in a new tab)

  13. Multimodal AI-Driven Biomarker for Early Detection of Cancer Cachexia

    Cancer cachexia is a metabolic syndrome characterized by substantial skeletal muscle loss, impacting cancer patients' survival and quality of life. Despite its clinical significance, early detection remains a challenge due to the lack of standardized diagnostic criteria and the reliance on indirect …

    usf Repository record for Multimodal AI-Driven Biomarker for Early Detection of Cancer Cachexia (opens in a new tab)

  14. Identifying Cancer Cachexia Factors Affecting Muscle Stem Cell Regeneration Capacity

    À la demande de l'auteur, le résumé a été retiré en raison de la nature confidentielle de la thèse. Il sera ajouté une fois la période d'embargo terminée. At the author’s request, the abstract has been removed due to the confidential nature of the thesis. It will be added once the embargo period …

    ottawa-retro Repository record for Identifying Cancer Cachexia Factors Affecting Muscle Stem Cell Regeneration Capacity (opens in a new tab)

  15. Small intestinal protein metabolism during cancer cachexia and chemotherapy in mice

    Cachexia is the leading cause of morbidity and mortality in patients with cancer. Mechanisms The effects of cancer cachexia and chemotherapy on small intestinal protein metabolism and the mechanisms regulating recovery are currently not known. Compromises to small intestinal protein metabolism may …

    ubc Repository record for Small intestinal protein metabolism during cancer cachexia and chemotherapy in mice (opens in a new tab) Download PDF for Small intestinal protein metabolism during cancer cachexia and chemotherapy in mice (opens in a new tab)

Page 1 of 7